NEW YORK — More than half of all U.S. adults reported an interest in trying cannabis-infused products, with beverages leading the way, according to findings from consumer insights company MRI-Simmons, New York.
The company’s 2022 National Cannabis Study revealed 58% of adults are interested in cannabis-infused products—up from 48% in 2019. Pro-legalization attitudes have also evolved, with 65% of Americans now agreeing cannabis and marijuana should be legal.
Click through to read more findings from the report …
Consumer Product Interest
When asked which of the following cannabis-infused products adults would be interested in trying, here’s what they said, according to MRI-Simmons' study:
- Tea: 34%
- Skin care (CBD): 32%
- Soft drinks: 31%
- Coffee: 30%
- Food: 30%
- Bedding (CBD): 28%
- Beauty products (CBD): 28%
- Beer or cocktails: 27%
- Liquor: 26%
- Dog treats: 22%
“The thirst for cannabis products is growing,” said Karen Ramspacher, senior vice president of innovation and insights at MRI-Simmons. “Beverages, skin care and beauty products have led the charge among the 147 million Americans who are interested. Cannabis is posed to disrupt and excite many categories. Mainstream brands need to prepare to adapt their products and adopt this valuable cannabis audience.”
The number of consumers supporting cannabis or marijuana legalization has increased 12% from 2019 to 65%. Supporters tend to be younger, with a medium age of 45, MRI-Simmons found.
Twenty percent of consumers said it should not be legal while 15% said they didn’t know.
Seventy-three percent of consumers said they agreed legalizing cannabis is a good way to add to tax revenue, and 70% said legalizing marijuana cuts down on illegal drug traffic.
Those responses, from 2022, weren’t far off from what people agreed with in 2019. A couple statements saw a significant jump, though.
In 2019, 40% of consumers said they would try marijuana if it were legal where they lived. That jumped to 50% in 2022, according to MRI-Simmons. People are also paying closer attention to developments in the legalization of cannabis—36% were following this in 2019, while 46% of consumer said they followed legalization developments in 2022.
About the Study
The 2022 MRI-Simmons National Cannabis Study was conducted using a nationally representative online sample of more than 5,000 respondents. MRI-Simmons, New York, is a leading provider of insights to the American consumer. The company empowers advertisers, agencies and media companies with deeper insights into the “why” behind consumer behavior, according to its website.